Related Experiment Videos

Possible involvement of dopaminergic neurotransmitter system in dichlorvos induced delayed neurotoxicity

Sanjeev Choudhary1, Geetu Raheja, Vandana Gupta

  • 1Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh -160 012, India.

Journal of Biochemistry, Molecular Biology, and Biophysics : JBMBB : the Official Journal of the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB)
|August 21, 2002
PubMed

Insights

Dichlorvos exposure disrupts the dopamine system, causing delayed neurotoxicity. Nimodipine protects against these effects by preserving dopamine system function.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Organophosphate-induced delayed neurotoxicity (OPIDN) is a severe neurological condition.
  • The role of the dopaminergic system in OPIDN pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the dopaminergic system's involvement in dichlorvos-induced delayed neurotoxicity.
  • To evaluate nimodipine's protective effects against dichlorvos-induced neurotoxicity.

Main Methods:

  • Rats were administered a single dose of dichlorvos (200 mg/kg).
  • Dopamine, norepinephrine, tyrosine hydroxylase (TH), dopamine-beta-hydroxylase, and monoamine oxidase (MAO) levels and activities were measured.
  • Dopamine D2 receptor binding was analyzed using Scatchard plots.
  • Nimodipine was co-administered with dichlorvos to assess its protective efficacy.

Main Results:

  • Dichlorvos significantly increased dopamine and norepinephrine levels and TH and dopamine-beta-hydroxylase activities, while decreasing MAO activity.
  • Dopamine D2 receptor analysis showed a significant decrease in both K(d) and B(max).
  • Nimodipine administration prevented these neurochemical alterations and ameliorated behavioral deficits.

Conclusions:

  • Alterations in the dopamine system are implicated in the mechanisms of dichlorvos-induced delayed neurotoxicity.
  • Nimodipine demonstrates protective efficacy against OPIDN by maintaining dopaminergic neurotransmitter system homeostasis.

Related Concept Videos